We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+7.72%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$812M
AUM Growth
-$10.4M
(-1.3%)
Cap. Flow
-$23.2M
Cap. Flow
% of AUM
-2.86%
Top 10 Holdings %
Top 10 Hldgs %
40.99%
Holding
68
New
20
Increased
15
Reduced
16
Closed
14
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$33.3M |
| 2 |
McKesson
MCK
|
+$31.1M |
| 3 |
ADVM
Adverum Biotechnologies
ADVM
|
+$20.8M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$18.6M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$18.1M |
Top Sells
| 1 |
Medtronic
MDT
|
+$37.6M |
| 2 |
AGN
Allergan Inc
AGN
|
+$28.8M |
| 3 |
Zimmer Biomet
ZBH
|
+$26.6M |
| 4 |
Universal Health Services
UHS
|
+$26.1M |
| 5 |
Agilent Technologies
A
|
+$19.9M |
Sector Composition
| 1 | Healthcare | 74.09% |
| 2 | Technology | 2.68% |
| 3 | Communication Services | 1.77% |
| 4 | Industrials | 0.7% |
| 5 | Financials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insmed
INSM
$23.8B
| $14.2M | 1.75% |
+1,090,624
| New | +$16.4M |
|
|
ITCI
27
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $13.8M | 1.69% |
1,003,496
+24,050
| +2% | +$361K |
|
28
Standard BioTools
LAB
$329M
| $13.7M | 1.69% |
559,622
+167,082
| +43% | +$4.7M |
|
|
WCG
29
DELISTED
Wellcare Health Plans, Inc.
WCG
| $13.6M | 1.67% |
+225,033
| New | +$14.9M |
|
|
30
Universal Health Services
UHS
$8.96B
| $12.9M | 1.59% |
123,792
-245,811
| -67% | -$26.1M |
|
31
BioMarin Pharmaceuticals
BMRN
$11.4B
| $12.8M | 1.57% |
177,079
-291,021
| -62% | -$19.1M |
|
32
Puma Biotechnology
PBYI
$428M
| $12.2M | 1.5% |
+51,025
| New | +$10.5M |
|
33
ProQR Therapeutics
PRQR
$250M
| $12.1M | 1.49% |
+765,232
| New | +$12.3M |
|
34
Accuray
ARAY
$32.7M
| $12M | 1.48% |
1,653,128
-213,132
| -11% | -$1.73M |
|
|
CIVI
35
DELISTED
Civitas Solutions, Inc.
CIVI
| $9.67M | 1.19% |
+619,236
| New | +$10.1M |
|
|
KYTH
36
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $9.22M | 1.14% |
281,479
-278,877
| -50% | -$9.82M |
|
37
Align Technology
ALGN
$13B
| $8.93M | 1.1% |
172,772
-2,680
| -2% | -$146K |
|
|
CYBX
38
DELISTED
CYBERONICS INC
CYBX
| $8.85M | 1.09% |
+172,900
| New | +$9.97M |
|
|
CSII
39
DELISTED
Cardiovascular Systems, Inc.
CSII
| $8.75M | 1.08% |
370,208
-123,137
| -25% | -$3.5M |
|
|
FLXN
40
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $8.51M | 1.05% |
465,933
-38,150
| -8% | -$552K |
|
|
LOXO
41
DELISTED
Loxo Oncology, Inc
LOXO
| $7.09M | 0.87% |
+540,300
| New | +$7.01M |
|
|
AKAO
42
DELISTED
Achaogen Inc
AKAO
| $6.9M | 0.85% |
770,422
+121,543
| +19% | +$1.24M |
|
43
Eledon Pharmaceuticals
ELDN
$310M
| $6.27M | 0.77% |
+2,558
| New | +$7.27M |
|
|
HMSY
44
DELISTED
HMS Holdings Corp.
HMSY
| $5.72M | 0.7% |
303,571
-262,022
| -46% | -$5.3M |
|
|
SGEN
45
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.77M | 0.59% |
+128,230
| New | +$5.04M |
|
|
CLVS
46
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.54M | 0.56% |
+100,000
| New | +$4.18M |
|
47
eHealth
EHTH
$48.6M
| $4.29M | 0.53% |
+177,788
| New | +$4.85M |
|
48
Agios Pharmaceuticals
AGIO
$2.37B
| $3.02M | 0.37% |
+49,200
| New | +$2.12M |
|
49
Prothena Corp
PRTA
$441M
| $2.79M | 0.34% |
125,973
-244,547
| -66% | -$5.18M |
|
|
ICPT
50
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $524K | 0.06% |
2,212
+1,150
| +108% | +$293K |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO